Prefilled Syringe Industry is Expected to Reach $ 14.4 Billion by 2031 - Gerresheimer AG, Sanofi, Terumo Corporation, B. Braun

Global Prefilled Syringe Market reached USD 6.4 billion in 2022 and is expected to reach USD 14.4 billion by 2031 growing with a CAGR of 10.9% during the forecast period 2024-2031.

The prefilled syringe market is expanding rapidly, driven by its use in treating chronic diseases like arthritis, diabetes, and cancer. Prefilled syringes offer a more convenient, faster, and safer method of drug delivery compared to traditional syringes. Key growth factors include the rising prevalence of chronic diseases, increased demand for self-administration, technological advancements, and growing FDA approvals. With benefits such as convenience, safety, and precise dosing, prefilled syringes are becoming the preferred option for drug delivery in healthcare.

Get a Free Sample Research PDF: https://www.datamintelligence.com/download-sample/pre-filled-syringes-market

Key Development:

On June 8, 2023, Techdow USA launched its generic version of Lovenox (Enoxaparin Sodium - Preservative Free) in prefilled syringes, following FDA approval. Enoxaparin, a complex blend of low molecular weight substances derived from heparin, requires precise manufacturing methods.

On October 24, 2022, Hikma Pharmaceuticals introduced the first FDA-approved prefilled syringe of Succinylcholine Chloride Injection, used for anesthesia and muscle relaxation during surgery.

On April 18, 2023, CSL Behring received FDA approval for a 50mL prefilled syringe of Hizentra, the first ready-to-use immune globulin for patients with Primary Immunodeficiency or CIDP.

Market Trends:

Rising FDA approvals for prefilled syringes are expected to drive global market growth. The FDA rigorously evaluates these products for quality, reliability, and performance, reviewing data from clinical trials, preclinical studies, and manufacturing processes. Recently, the FDA has also approved prefilled syringes as combination products, which package drugs or biological products with the delivery device, enhancing convenience and adherence. On March 3, 2023, Nexus Pharmaceuticals received FDA approval for Emerphed (ephedrine sulfate injection) in prefilled syringes, including a 10mL option, the first of its kind. On February 9, 2022, Takeda's Takhzyro injection prefilled syringe was approved for preventing hereditary angioedema attacks, offering a ready-to-use alternative to vial injections.

Segment Covered in the Prefilled Syringe Market:

By Product Type: Needle Free PFS, Needled PFS

By Material Type: Glass Prefilled Syringes, Plastic Prefilled Syringes

By Design: Single Chamber PFS, Dual Chamber PFS

By Application: Diabetes, Rheumatoid Arthritis, Ophthalmology, Anaphylaxis, Others

Major Key Players:

• Gerresheimer AG
• Sanofi
• Terumo Corporation
• B. Braun
• Baxter International
• West Pharmaceutical Services, Inc.
• Becton, Dickinson, and Company
• SCHOTT AG
• Catalent Inc.
• Cardinal Health Inc.

*Note:

Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.

Related Reports:

Safety Syringes Market: https://www.datamintelligence.com/research-report/safety-syringes-market

Disposable Syringes Market: https://www.datamintelligence.com/research-report/disposable-syringes-market

IV Flush Syringe Market: https://www.datamintelligence.com/research-report/iv-flush-syringe-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Get Customization in the report as per your requierments: https://www.datamintelligence.com/customize/pre-filled-syringes-market

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.